Ospedale Regionale di Lugano Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00792584
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Hospital Lugano | Neurosurgery, Ospedale Regionale Lugano | Ospedale Regionale di Lugano | Ospedale Regionale di Lugano - Civico | Paolo Maino MD PhD, Sponsor Investigator | Servizio Trasfusionale, Lugano

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 2)

Brain Injuries, Traumatic (Phase 2)

Multiple Sclerosis (Phase 4)

Multiple Sclerosis, Relapsing-Remitting (Phase 4)

Psychomotor Agitation (Phase 4)

Restless Legs Syndrome (Phase 4)

Sclerosis (Phase 4)

Syndrome (Phase 4)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 13